Etana Biotechnologies

High-quality, affordable and innovative biopharmaceuticals for Indonesia

Etana Biotechnologies was founded in 2014, is headquartered in Jakarta, Indonesia, lists 51–200 employees, and has $8.0M in recorded funding across 2 rounds.

Headquarters
Jakarta
Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Series BMar 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

PT Etana Biotechnologies Indonesia (Etana) is an Indonesian biopharmaceutical company established in 2014, focused on manufacturing, research and development, and marketing of high-quality, affordable, and innovative biologics. The company specializes in recombinant gene technology, monoclonal antibodies (MABs), and vaccine production, targeting oncology and infectious disease treatment areas. Etana has been officially designated as a Center of Excellence for Vaccine and Biotechnology by Indonesia's Ministry of Health, and has secured investment from DEG (Deutsche Investitions- und Entwicklungsgesellschaft) to fund its oncology pipeline. The company maintains strategic partnerships with global biopharmaceutical firms including CanSinoBio and DEG Impulse for digital transformation of vaccine production.

Summary

Etana Biotechnologies is a Biotech company based in Jakarta, Indonesia, founded in 2014. It lists 51–200 employees. It has raised $8.0M in total across 2 rounds, most recently a $8.0M Series B round in Mar 2023. Investors include DEG, Legend Capital and Yunfeng Capital.

Funding History

Series BSeries BMar 2023
$8.0M

Sign up to see all 2 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Etana Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/etana-biotechnologies"><img src="https://indexed.vc/api/badge/company/etana-biotechnologies" alt="Etana Biotechnologies on Indexed.vc" width="260" height="76" /></a>